Latest TB research highlights

Latest TB research highlights:

— News-Medical.Net: Global fight against TB misses 2020 WHO milestones, despite progress in certain age groups

In a study, published in The Lancet Infectious Diseases, researchers assessed the global, national, and regional burden and trends in TB using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021.

— University College London: New classification of TB to support efforts to eliminate the disease

A new way to classify TB, aiming to improve focus on the early stages of the disease, was published in The Lancet Respiratory Medicine. The International Consensus for Early TB (ICE-TB) framework was developed by a diverse group of 64 experts.

— Zendal Group: MTBVAC, the first TB vaccine derived from a human source, begins clinical trials in adults in India

Bharat Biotech International Limited in collaboration with Biofabri have started a series of clinical trials to evaluate the safety, immunogenicity and efficacy of MTBVAC in India. MTBVAC is the only vaccine against TB in clinical trials based on a genetically modified form of the pathogen isolated from humans Mycobacterium tuberculosis.

— Medical Xpress: Study finds association between TB infection and increased risk of various cancers

A population-wide observational study to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) showed an association between TB and cancer, with those with current or previous TB more likely to have a diagnosis of a variety of cancers, including lung, blood, gynecological and colorectal cancers.

Check out the latest edition of the TB Online Weekly Newsletter (#11, 5 April 2024) for more TB research updates.

The TB Online Weekly Newsletter is brought to you by TB CAB and EATG. Subscribe to the newsletter here.